Results 191 to 200 of about 68,039 (253)
\Stopping Dysmenorrhea: A Systematic Review of Drugs Inhibiting Uterine Contractions. [PDF]
J Endometr Uterine DisordKahl T +5 more
europepmc +1 more source
Efficacy of indomethacin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A comprehensive meta-analysis of randomized controlled trials. [PDF]
World J GastroenterolTian F, Huang ZC, Khizar H, Qiu K.
europepmc +1 more source
<i>Levilactobacillus brevis</i> KU15147 Attenuates MIA-Induced Osteoarthritis by Modulating Inflammatory Responses and Cartilage Metabolism. [PDF]
J Microbiol BiotechnolLee NK, Lee Y, Choi M, Park E, Paik HD.
europepmc +1 more source
Analgesic and anti-inflammatory activities of Vitex trifolia extract and development of a topical herbal cream. [PDF]
J Ayurveda Integr MedPaduka W +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Pharmacology of Indomethacin
Headache, 2016Background Over 50 years ago, indomethacin emerged as an extremely potent non‐steroidal anti‐inflammatory drug (NSAID) during a massive effort to find effective anti‐inflammatory and analgesic medications. The 1960s saw acetic acid derivatives developed into indomethacin, diclofenac, and sulindac, and propionic ...
exaly +3 more sources
Indomethacin and prostaglandins
European Journal of Pharmacology, 1972Abstract The effects of indomethacin on inflammation mediators histamine, 5-hydroxytryptamine, bradykinin and prostaglandin E 2 have been studied. Indomethacin, 10–160 ωg/ml, exhibits an inhibitory effect on the contractions induced by each one of the studied mediators on isolated rat uterus and guinea pig ileum.
M di Rosa
exaly +3 more sources
Drug Development and Industrial Pharmacy, 1994 AbstractThe prepared film-coated directly-compressed indo-methacin, indomethacin sodium and indomethacin meglumine tablets, plain indomethacin in hard gelatin capsule and the commercial product “Indocid” capsules, were subjected to bioavailability testing in six healthy volunteers. Each treatment was given as single oral dose of 50 mg.
Hamed El-shattawy +4 more
openaire +2 more sources
Pharmacokinetics of indomethacin
Clinical Pharmacology & Therapeutics, 1975Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously [iv], 25, 50, and 100 mg orally, 100 mg rectally, and 25 mg three times daily [tid]. In 8 other normal subjects and in 5 patients a 50‐mg oral dose of indomethacin was given and the indomethacin concentration was followed
G, Alván +4 more
openaire +2 more sources
Journal of Toxicology: Clinical Toxicology, 1986
Two cases of indomethacin poisoning with supporting analytical data are described and the literature, which is limited to two reports, is reviewed. In overdose, indomethacin may produce the following non-life threatening symptoms: nausea, vomiting, abdominal pain, anorexia, drowsiness, headache, tinnitus, restlessness and agitation.
T M, Sheehan, D A, Boldy, J A, Vale
openaire +2 more sources
Two cases of indomethacin poisoning with supporting analytical data are described and the literature, which is limited to two reports, is reviewed. In overdose, indomethacin may produce the following non-life threatening symptoms: nausea, vomiting, abdominal pain, anorexia, drowsiness, headache, tinnitus, restlessness and agitation.
T M, Sheehan, D A, Boldy, J A, Vale
openaire +2 more sources
Archives of Dermatology, 1966
Twelve psoriatics have been observed in a controlled study with indomethacin, a nonsteroidal anti-inflammatory agent, as the test drug. No greater subjective or objective benefit was noted from indomethacin than from the placebo.
openaire +2 more sources
Twelve psoriatics have been observed in a controlled study with indomethacin, a nonsteroidal anti-inflammatory agent, as the test drug. No greater subjective or objective benefit was noted from indomethacin than from the placebo.
openaire +2 more sources